Get ready for Ax-S Thursdays, the FREE e-Conference Series on integrating clinical research into modern healthcare delivery.

We created the Ax-S Thursdays e-Conference Series to deliver deep, actionable knowledge on clinical trial innovation, including decentralization, repurposing, and Expanded Access protocols to effectively bring clinical research into healthcare delivery.

Premium Pass

Ax-S Pharma Premium Membership includes guaranteed access to all e-Conference Series programming.

Exhibiting and Commercial Partnering

The 2020 Report Card on Pre-Market Access to COVID19 Diagnostics, Therapeutics, and Vaccines

Thursday, Feb 11, 2021 | 2:00pm – 3:30pm Eastern

Networking/Partnering afterward

Paul Aliu, PharmD | Peter Marks, MD, PhD | Michael Joyner, MD | Lee Gehrke, PhD

The year 2020 presented the public with an unprecedented healthcare delivery challenge:  A rapidly spreading, global contagion with poor characterization and serious to fatal outcomes for segments of the infected population.  This session reviews the countermeasures developed in response to the COVID-19 pandemic and examines whether pre-market access programs -including EUA and Expanded Access- were adequately utilized to meet the world’s urgent healthcare and research needs.


Paul Aliu, PharmD, Global Head Medical Governance, Chief Medical Office, Novartis
Peter Marks, MD, PhD, Director, Center for Biologics Evaluation and Research, FDA
Michael Joyner, MD, Medical Faculty, Mayo Clinic
Lee Gehrke, PhD, Professor, Institute for Medical Engineering and Science, MIT

LiveCast 1

Includes 24/7 access from Monday Feb 8 through Sunday Feb 14

Free for first 200 registrations

Smarter Data Capture in Hybrid Clinical Programs

Thursday, Feb 25, 2021 | 12:00pm – 1:30pm Eastern

Networking/Partnering afterward

Amy Abernethy | Michael Kurilla | Craig Lipset | Tobias Polak, PhD

This topic returns with a look to the future of data generation in healthcare. Will we have uniform standards? Will we achieve seamless integration between non-research personal health data and research data? What will this require? Finally, can the clinical use and outcomes of new treatments take a greater role in bringing products to market, supporting -not replacing- randomized clinical trials? The speakers will present their views on our progress toward a true “learning healthcare system”.

Amy Abernethy, MD, PhD, Principal Deputy Commissioner and Acting Chief Information Officer, FDA
Michael Kurilla, MD, PhD,
Director, Clinical and Translational Science Awards (CTSA) Program, NCTS, NIH
Craig Lipset, Founder, Decentralized Trial Research Alliance
Tobias Polak, MSc, Department of Health Technology Assessment, Erasmus MC

LiveCast 2

Includes 24/7 access from Monday Feb 22 through Sunday Feb 28

Free for first 500 registrations

Decentralized, Virtual, and Hybrid Clinical Trials

Thursday, Mar 11, 2021 | 12:00pm – 1:30pm Eastern

Networking/Partnering afterward

Craig Lipset | Suanna Bruinooge | Michelle Longmire | Steve Usdin

A broader, smarter clinical development process requires inclusivity – not just a wider range of patient phenotype and demographic, but also a greater range of location – non-traditional trial sites, communities who are not part on the roster of traditional research centers, families who cannot easily travel for in-person visits. This panel explores how crucial decentralization is to the fusion of research and healthcare.

Craig Lipset Founder, Clinical Innovation Partners
Suanna Bruinooge, MPH Director of Research Strategy, CENTRA, ASCO
Michele Longmire, MD Founder and CEO, Medable
Steve Usdin, Senior Editor, BioCentury

LiveCast 3

Includes 24/7 access from Monday March 8 through Sunday March 14

Free for first 500 registrations

Platform Trials, Repurposing Studies, and Clinical Discoveries

Thursday, Mar 25, 2021 | 12:00pm – 1:30pm Eastern

Networking/Partnering afterward

Merit Cudkowicz | Suanna Bruinooge | Kevin Weatherwax | Paul Aliu

At the last two annual Expanded Access Summits (2019 and 2020), FDA’s Dr. Janet Woodcock emphasized the growing role for “Platform Trials”, which can include both non-marketed and marketed products and dynamically add experimental treatment regimens for targeted groups of patients. This session explores the frontier of the “Learning Healthcare System” whereby larger segments of a disease population can participate in interventional trials.

Merit Cudkowicz, MD, Director, Sean M. Healey & AMG Center for ALS at Mass General Hospital
Suanna Bruinooge, MPH Director of Research Strategy, CENTRA, ASCO
Kevin Weatherwax, Mangain Director, Michigan Institute for Clinical and Health Research, University of Michigan Medical System
Paul Aliu, PharmD Global Head Medical Governance, Chief Medical Office, Novartis Pharmaceuticals

LiveCast 4

Includes 24/7 access from Monday Mar 22 through Sunday Mar 28

Free for first 500 registrations

CME Accreditation

We now offer Continuing Medical Education units on selected modules and webcasts.


Headline Sponsors

Community Partners